Table 3.
Association between continuous serum bicarbonate and summary cognitive function domains in SPRINT MIND participants
Model 1, n=2853 | Model 2, n=2853 | Model 3, n=2804 | ||||
---|---|---|---|---|---|---|
Domain | Estimate (SEM) | P Value | Estimate (SEM) | P Value | Estimate (SEM) | P Value |
Global cognitive function | 0.02 (0.005) | <0.01 | 0.02 (0.006) | <0.01 | 0.01 (0.006) | 0.01 |
Executive function | 0.02 (0.006) | <0.01 | 0.02 (0.006) | 0.004 | 0.02 (0.006) | 0.002 |
Memory | 0.01 (0.006) | 0.07 | 0.008 (0.006) | 0.20 | 0.006 (0.006) | 0.35 |
Attention/concentration | 0.01 (0.006) | 0.06 | 0.01 (0.006) | 0.04 | 0.01 (0.006) | 0.06 |
Language | −0.008 (0.006) | 0.19 | −0.009 (0.006) | 0.15 | −0.009 (0.006) | 0.17 |
Model 1 adjusted for age, network, education, sex, and race. Model 2 adjusted for model 1 components as well as cardiovascular disease, systolic BP, use of diuretics, and antiacidosis medications (sodium bicarbonate, sodium citrate, citric acid/sodium citrate). Model 3 adjusted for model 2 components as well as eGFR and log-transformed urine albuminuria.